ArticleScience advances2018
Global expansion of
Abstract read
In one paragraph
Article in Science advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
103 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Genotypic diversity of multi- and extensively drug-resistant Mycobacterium tuberculosis in Iran: a systematic review and meta-analysis.BMC infectious diseases · 2025Pooled it
- Variation in Mycobacterium tuberculosis population structure in Iran: a systemic review and meta-analysis.BMC infectious diseases · 2021Pooled it
- Genomic epidemiology of Mycobacterium tuberculosis in Santa Catarina, Southern Brazil.Scientific reports · 2020Trial
- Targeted next-generation sequencing of sputum for diagnosis of drug-resistant TB: results of a national survey in Democratic Republic of the Congo.Scientific reports · 2020Trial
- Evolving dynamics of H5Nx avian influenza in China revealed by long-term wild bird surveillance.Nature communications · 2026Article
- Discrimination betweenOne health (Amsterdam, Netherlands) · 2026Article
- Dormancy regulon reduction was pivotal to the evolution of Mycobacterium tuberculosis.Nature communications · 2026Article
- The global phylogeography of rapidly expanding multidrug resistant Ural lineage 4.2 Mycobacterium tuberculosis.Nature communications · 2026Article
- Burden of Bacterial Antimicrobial Resistance in Libya, 1970-2024: A Systematic Meta-Analysis with Projections to 2050.Antibiotics (Basel, Switzerland) · 2026Review
- Ancient DNA insights into diverse pathogens and their hosts.Nature reviews. Genetics · 2026Review
- Genomic epidemiology of theFrontiers in microbiology · 2026Article
- Drug Exposure Dictates Evolutionary Dynamics of Drug-Resistant Tuberculosis: A Longitudinal Cohort Study in Beijing, China.Infection and drug resistance · 2026Article
- Phylodynamic analysis reveals disparate transmission dynamics of Mycobacterium tuberculosis complex lineages in Botswana.Scientific reports · 2025Article
- Cross-continental transmission and host adaptation ofiMetaOmics · 2025Article
- VirPhyKit: An Integrated Toolkit for Viral Phylogeographic Analysis.Ecology and evolution · 2025Article
- Article
- Molecular Epidemiology ofMicroorganisms · 2025Review
- Ecology, global diversity and evolutionary mechanisms in the Mycobacterium tuberculosis complex.Nature reviews. Microbiology · 2025Review
- South Asian origin and global transmission history ofmSystems · 2025Article
- Phylogeographic History of Tomato Chlorosis Virus.Viruses · 2025Article
43 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
30 authors.
Ola B BrynildsrudDivision of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway.ORCID 0000-0001-7566-4133
Caitlin S PepperellDivision of Infectious Disease, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.ORCID 0000-0002-6324-1333
Philip SuffysLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, Avenida Brasil 4365, C.P. 926, Manguinhos 21040-360, Rio de Janeiro, Brazil.
Louis GrandjeanDepartment of Paediatric Infectious Diseases, Imperial College London, W2 1NY, London, UK.ORCID 0000-0002-1457-8327
Johana MonteserinInstituto Nacional de Enfermedades Infecciosas, ANLIS Carlos Malbran, Buenos Aires, Argentina.ORCID 0000-0002-3597-4169
Nadia DebechDivision of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway.
Jon BohlinDivision of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway.ORCID 0000-0002-0992-1311
Kristian AlfsnesDivision of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway.ORCID 0000-0002-5903-9239
John O-H PetterssonDivision of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway.
Ingerid KirkeleiteDivision of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway.
Fatima FandinhoLaboratorio de Bacteriologia da Tuberculose, Centro de Referłncia Professor Helio Fraga-Jacarepagu, Estrada de Curicica 2000, Brazil.
Marcia Aparecida da SilvaLaboratorio de Bacteriologia da Tuberculose, Centro de Referłncia Professor Helio Fraga-Jacarepagu, Estrada de Curicica 2000, Brazil.
Joao PerdigaoInstituto de Investigao do Medicamento, Faculdade de Farmcia, Universidade de Lisboa, Lisboa, Portugal.ORCID 0000-0002-0339-1305
Isabel PortugalInstituto de Investigao do Medicamento, Faculdade de Farmcia, Universidade de Lisboa, Lisboa, Portugal.
Miguel ViveirosUnidade de Microbiologia Medica, Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa, Portugal.
Taane ClarkFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
Maxine CawsLiverpool School of Tropical medicine, Department of Clinical Sciences, Liverpool, UK.
Sarah DunstanPeter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0001-7873-933X
Phan Vuong Khac ThaiPham Ngoc Thach Hospital for TB and Lung Diseases, Ho Chi Minh City, Vietnam.
Beatriz LopezInstituto Nacional de Enfermedades Infecciosas, ANLIS Carlos Malbran, Buenos Aires, Argentina.
Viviana RitaccoInstituto Nacional de Enfermedades Infecciosas, ANLIS Carlos Malbran, Buenos Aires, Argentina.ORCID 0000-0003-1217-0229
Andrew KitchenDepartment of Anthropology, University of Iowa, Iowa City, IA 52242, USA.ORCID 0000-0002-4817-390X
Tyler S BrownDivision of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA.
Dick van SoolingenCenter for Infectious Disease Research, Diagnostics and Perinatal Screening, National Institute for Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, Netherlands.
Mary B O'NeillDepartment of Medical Microbiology and Immunology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.ORCID 0000-0003-3003-495X
Kathryn E HoltFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.ORCID 0000-0003-3949-2471
Edward J FeilMilner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK.ORCID 0000-0003-1446-6744
Barun MathemaMailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032, USA.
Francois BallouxUCL Genetics Institute, University College London, London WC1E 6BT, UK.ORCID 0000-0003-1978-7715
Vegard EldholmDivision of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway.ORCID 0000-0001-6721-3375
Funding
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007133 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI PERNA, NICOLE T · 1985 to 2023
$16.5MDrifting to victory: resolving the paradox of M.tuberculosis evolutionR01AI113287 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI Caitlin S Pepperell · 2015 to 2026
$6.5MMedical Research Council MR/P007597/1NIAID NIH HHS R01 AI113287NIGMS NIH HHS T32 GM007133
Abstract
On the basis of population genomic and phylogeographic analyses of 1669
Indexed as
Adaptation, BiologicalAfricaAmericasBiological EvolutionDrug Resistance, BacterialEuropeGenetic VariationHuman MigrationHumansMycobacterium tuberculosisPhylogeographyPolymorphism, Single NucleotideTuberculosis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.